Lipella Pharms Inc (LIPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 118 | 151 | 0 | 0 | 33 |
| Gross Profit | 118 | 151 | N/A | N/A | 33 |
| Operating Expenses | 1,203 | 510 | 713 | 781 | 770 |
| Operating Income | -1,084 | -359 | -713 | -781 | -737 |
| Interest Expense | 5 | 5 | 2 | 2 | 2 |
| Other Income | 22 | 0 | 1 | 1 | 0 |
| Pre-tax Income | -1,068 | -364 | -714 | -782 | -738 |
| Net Income Continuous | -1,068 | -364 | -714 | -782 | -738 |
| Net Income | $-1,068 | $-364 | $-714 | $-782 | $-738 |
| EPS Basic Total Ops | -1.52 | -0.64 | -1.36 | -1.60 | -1.52 |
| EPS Basic Continuous Ops | -1.49 | -0.58 | -1.39 | -1.62 | -1.53 |
| EPS Diluted Total Ops | -1.52 | -0.64 | -1.36 | -1.60 | -1.52 |
| EPS Diluted Continuous Ops | -1.49 | -0.58 | -1.39 | -1.62 | -1.53 |
| EBITDA(a) | $-1,084 | $-359 | $-713 | $-781 | $-737 |